Akebia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	342	427	427	241	106	400
Market Cap Growth	-66.26%	0.03%	77.06%	127.10%	-73.44%	-3.52%
Enterprise Value	383.62	290.74	417.58	241.99	110.82	381.47
Last Close Price	1.27	1.61	1.90	1.24	0.58	2.26
Forward PE	-	82.56	18.72	18.72	18.72	18.72
PEG Ratio	-	2.23	2.23	2.23	2.23	2.23
PS Ratio	1.50	1.81	2.67	1.24	0.36	1.89
PB Ratio	12.72	13.10	-8.69	-7.89	20.31	5.41
P/FCF Ratio	5.81	6.31	-	-	-	-
P/OCF Ratio	5.78	6.29	-	-	-	-
EV/Sales Ratio	1.65	1.23	2.61	1.24	0.38	1.80
EV/EBITDA Ratio	31.63	11.74	-	-	-	-
EV/EBIT Ratio	35.37	12.37	-	-	-	-
EV/FCF Ratio	6.39	4.29	-	-	-	-
Debt / Equity Ratio	1.33	1.48	-0.86	-0.85	12.05	0.46
Debt / EBITDA Ratio	7.44	1.95	-	-	-	-
Debt / FCF Ratio	0.81	0.71	-	-	-	-
Net Debt / Equity Ratio	-4.15	-4.19	0.20	-0.02	0.87	-0.25
Net Debt / EBITDA Ratio	-17.31	-5.51	0.74	-0.08	-0.11	0.08
Net Debt / FCF Ratio	-1.89	-2.02	0.24	-0.03	-0.06	0.07
Asset Turnover	0.63	0.79	0.69	0.65	0.66	0.36
Inventory Turnover	3.09	2.48	3.96	3.98	2.94	3.09
Quick Ratio	1.30	1.42	1.07	0.82	1.01	0.77
Current Ratio	1.40	1.55	1.41	1.18	1.43	1.04
Return on Equity (ROE)	-27.56%	64.49%	174.03%	409.60%	-237.83%	-175.37%
Return on Assets (ROA)	1.43%	11.30%	-21.83%	-15.48%	-18.25%	-45.08%
Return on Invested Capital (ROIC)	-	188.72%	-35.85%	-61.01%	-247.57%	-340.46%
Return on Capital Employed (ROCE)	2.63%	13.30%	-35.85%	-25.12%	-32.65%	-72.94%
FCF Yield	17.22%	15.84%	-	-	-	-
Buyback Yield / Dilution	-21.26%	-21.91%	-12.53%	-2.56%	-10.14%	-19.85%
Total Shareholder Return	-21.26%	-21.91%	-12.53%	-2.56%	-10.14%	-19.85%

SEC Filings: 10-K · 10-Q